baber/WOPTO huggingface dataset:
Patent CA-3142172-A1 (CA)
Inventor: CHANDRASHEKAR PADMASSRI
IPC: G06F40/279
Filed: 2021-12-14
Abstract: Systems and methods are provided for presenting an advertisement to a first participant of a plurality of participants of a conversation based on interests of other participants of the conversation. The conversation is monitored and a profile of the first participant is accessed. An interest category of a first interest term included in the profile is identified. A second interest temi is identified from a portion of the conversation provided by a second participant of the plurality of participants. In response to determining that the second interest term is different from the first interest term and that the second interest term is in the identified interest category, an advertisement matching the second interest term is identified and generated for presentation on user equipment of the first participant.
Patent CA-3143679-A1 (CA)
Title: Combination of hepatitis b virus (hbv) vaccines and hbv-targeting rnai
Inventor: HORTON HELEN
IPC: C12N15/113
Filed: 2020-06-18
Abstract: Therapeutic combinations of hepatitis B virus (HBV) vaccines and an RNAi agent for inhibiting the expression of an HBV gene are described. Methods of inducing an immune response against HBV or treating an HBV-induced disease, particularly in individuals having chronic HBV infection, using the disclosed therapeutic combinations are also described.
Patent CA-3147297-A1 (CA)
Title: Methods and devices for single-cell based digital high resolution melt
Inventor: SINHA MRIDU
IPC: C12Q1/70
Filed: 2020-09-16
Abstract: Provided are devices, systems, and methods for the identification, quantification, and profiling of microscopic organisms. The methods for the identification, quantification, and profiling of microscopic organisms include, for example, the selective enrichment of microscopic organisms from a heterogeneous sample; subsequent loading of the microscopic organisms into microfluidic channels or reaction chambers; direct amplification of nucleic acids from single, isolated microscopic organisms; and examination of amplification products using digital High Resolution Melting (HRM) analysis.
Patent CA-3148581-A1 (CA)
Title: Ensembles moteur de fond de trou, systemes et procedes
Inventor: BENNION BROCK
IPC: E21B17/03
Filed: 2020-08-21
Abstract: La présente invention concerne des conceptions de moteur de fond de trou améliorées. Dans un mode de réalisation illustratif, des paliers de butée primaire et secondaire qui sont maintenus en position par d'autres composants structuraux du moteur sans charge de compression de l'ensemble de palier entier sont positionnés à l'intérieur du carter de moteur pour une protection contre les déblais et les débris dans le fluide de forage. Dans certains modes de réalisation illustratifs, un train d'entraînement qui comprend au moins un joint flexible de section à plusieurs parties peut permettre d'obtenir un arbre flexible raccourci tout en convertissant suffisamment les forces excentriques de la source d'alimentation en rotation du mandrin.
Patent CA-3148995-A1 (CA)
Title: Enjoliveur multi-corps pour systemes de gonflage de pneumatique
Inventor: SHARKEY JAMES
IPC: B60C23/04
Filed: 2020-08-12
Abstract: Un enjoliveur comprend une base et un capot couplé rotatif à la base.
Patent CA-3151519-A1 (CA)
Title: Compositions and related methods for the ablation of m2 macrophages and myeloid derived suppressor cells
Inventor: RALPH DAVID
IPC: C07K16/28
Filed: 2020-08-19
Abstract: Compositions and methods for ablating CD206 expressing macrophages and/or CD206 expressing myeloid derived suppressor cells (MDSCs) are disclosed. In certain aspects, disclosed methods comprise administering to a subject in need thereof an effective dose of a compound comprising a dextran backbone and one or more CD206 targeting moieties and one or more therapeutic agents attached thereto. In certain aspects, the therapeutic agent comprises a metal. In further aspects, the therapeutic agent comprises a cytotoxic agent.
Patent CA-3153118-A1 (CA)
Inventor: SMITH KENNETH C
IPC: B65D5/42
Filed: 2022-03-23
Abstract: A blank of sheet material for foming a polygonal container, the blank including, a bottom panel, two opposing end panels, each end panel extending from an end edge of the bottom panel, two opposing outer side panels, each outer side panel extending from a side edge of the bottom panel, and an inner side panel extending from each top edge of one outer side panel of the two outer side panels and an outer side panel extending from each top edge of the one of the inner side panels, wherein each inner side panel includes a central portion, a corner portion extending from each side of the central portion, and an inner end portion extending from a side of each of the corner portions.
Patent CA-3154145-A1 (CA)
Title: Systems and methods for predicting manufacturing process risks
Inventor: FRIDLEY LILA
IPC: G06N3/08
Filed: 2020-09-10
Abstract: The present disclosure provides system, methods, and computer program products for predicting and detecting anomalies in a subsystem of a system. An example method may comprise (a) determining a first plurality of tags that are indicative of an operational performance of the subsystem. The tags can be obtained from (i) a plurality of sensors in the subsystem and (ii) a plurality of sensors in the system that are not in the subsystem. The method may further comprise (b) processing measured values of the first plurality of tags using an autoencoder trained on historical values of the first plurality of tags to generate estimated values of the first plurality of tags; (c) determining whether a difference between the measured values and estimated values meets a threshold; and (d) transmitting an alert that indicates that the subsystem is predicted to experience an anomaly if the difference meets the threshold.
Patent CA-3156709-A1 (CA)
Title: Account registration using a contactless card
Inventor: CODY LEA
IPC: G06Q20/40
Filed: 2020-11-24
Abstract: Account registration using a contactless card. A payment application executing on a device may receive a request to generate a payment account using a contactless card. The payment application may receive encrypted data from the contactless card and transmit the encrypted data to a server associated with the contactless card. The device may receive a push notification from the server and open an account application associated with the contactless card responsive to selection of the push notification. The account application may receive confirmation to generate the payment account using the contactless card and transmit the confirmation to the server. The device may open the payment application responsive to receiving verification of the encrypted data from the server. The payment application may fill form fields with account data received from the server and generate the payment account using the account data received from the server filled into the form fields.
Patent CA-3157089-A1 (CA)
Title: Stationary status resolution system
Inventor: HELWA MOHAMED
IPC: G01S13/52
Filed: 2020-12-09
Abstract: In some embodiments, a non-transitory computer-readable storage medium includes instructions to identify, based upon Doppler-speed determination from one or more radars, radar targets within a hitbox for determining a first stationary status of a vehicle based on tracking Doppler-speed radar targets in a hitbox region. The medium also includes instructions to identify, based upon the Doppler speed determination from the one or more radars, field-of-view (FOV) radar targets for determining a second stationary status based on a substantial number and a distribution of Doppler-speed determinations for the FOV radar targets. The medium also includes instructions to confirm, based on detecting a change in either of the first or the second stationary status of the vehicle, an acceleration sensed by an inertial measurement unit onboard the vehicle.
Patent CA-3160177-A1 (CA)
Title: Appareil et procede de compensation de passivation de batterie dans un dispositif medical
Inventor: LOCKRIDGE LARRY LEWIS
IPC: H01M10/42
Filed: 2020-12-11
Abstract: L'invention concerne un procédé de fonctionnement d'un dispositif médical consistant à activer un processeur dans le dispositif médical dans un mode de fonctionnement à faible puissance, à mesurer un premier niveau de tension de la batterie, à appliquer au moins une impulsion de décharge à la batterie en réponse au fait que le premier niveau de tension de la batterie est supérieur à un seuil de tension minimal de passivation prédéterminé et inférieur à un seuil de tension maximal de passivation prédéterminé, à mesurer un second niveau de tension de la batterie après l'au moins une impulsion de décharge, et à faire fonctionner le processeur dans le dispositif médical dans un mode de fonctionnement à puissance accrue afin de poursuivre le fonctionnement du dispositif médical uniquement en réponse au fait que le second niveau de tension est supérieur ou égal à un seuil de tension de fonctionnement prédéterminé, le seuil de tension de fonctionnement prédéterminé étant supérieur au seuil de tension minimal de passivation prédéterminé et inférieur ou égal au seuil de tension maximal de passivation prédéterminé.
Patent CA-3160361-A1 (CA)
Title: Improving accuracy of control valves using a long-stroke position converter
Inventor: BETLEY JUSTIN WALTER
IPC: F16K31/08
Filed: 2022-05-25
Abstract: A position transfer device is configured for use on a control valve. These configurations may convert a linear position of a closure member on the control valve to an angular position of magnets. A sensor in proximity to the magnets can generate a signal in response to the angular position. In one implementation, a valve positioner or controller can process the signal to identify the position of the closure member relative to a seat.
Patent CA-3161667-A1 (CA)
Inventor: KIM PIL HO
IPC: A61P31/06
Filed: 2020-12-16
Abstract: La présente invention concerne un nouveau dérivé de pyrimidine et une utilisation correspondante. Le dérivé de pyrimidine présente une excellente activité inhibitrice de MLK3 et une excellente activité inhibitrice de LRRK2 et peut donc être utilisé dans une composition pharmaceutique pour la prévention ou le traitement de cancers, de maladies infectieuses virales, de la maladie de Parkinson, de la stéatose hépatique non alcoolique et de la tuberculose.
Patent CA-3161867-A1 (CA)
Title: Composes et compositions pour le traitement de troubles du systeme nerveux central
Inventor: SPEAR KERRY L
IPC: C07D223/16
Filed: 2020-12-29
Abstract: La présente invention concerne des composés et des compositions pharmaceutiques de ceux-ci. L'invention concerne également des procédés de fabrication et d'utilisation des composés. Les composés peuvent être utilisés pour le traitement, la prévention, le diagnostic et/ou la gestion de divers troubles du SNC.
Patent CA-3162876-A1 (CA)
Inventor: ZHANG JINXING
IPC: H01B7/08
Filed: 2020-08-28
Abstract: Les modes de réalisation de la présente invention se rapportent au domaine technique des communications optiques, et concernent un câble composite photoélectrique et un système de communication optique. Le câble composite photoélectrique comprend un conducteur linéaire, une fibre optique et une gaine extérieure. La gaine extérieure est étroitement enroulée autour du conducteur et de la fibre optique, et le conducteur et la fibre optique sont disposés côte à côte. Le câble composite photoélectrique et le système de communication optique selon les modes de réalisation de la présente invention présentent une structure simple et un procédé de fabrication simplifié tout en garantissant qu'un câble optique et un câble électrique séparés l'un de l'autre puissent être formés, et que la surface de la section transversale du câble composite photoélectrique puisse être réduite.
Patent CA-3166136-A1 (CA)
Title: Transfer device with user-controlled venting
Inventor: FRAITES THOMAS J
IPC: A61J1/20
Filed: 2021-01-28
Abstract: A vial access device comprising a first housing comprising a vent body having a cover configured for reversibly hermetically sealing the vent body; a first spike having a proximal end and a distal end, the proximal end projecting from the first housing, the first spike having a fluid lumen and a vent lumen, each arranged parallel to the first longitudinal axis, the vent lumen in fluidic communication with the vent body; a shroud projecting the first housing and at least partially surrounding a portion of the first spike; the shroud configured to receive a vial or container; a connector member projecting from the first housing, the connector in fluid communication with the fluid lumen of the first spike. Methods of transferring solutions from medicament vials are also provided.
Patent CA-3166441-A1 (CA)
Title: System and method for extracting information on the spatial distribution of wavefronts
Inventor: GARCIA RICARDO OLIVA
IPC: G03B35/08
Filed: 2022-06-27
Abstract: The invention relates to an optical system (100) for capturing information on the two-dimensional and/or three-dimensional distribution of wavefronts from a plurality of images, wherein the optical system comprises at least one sensor (101) for capturing images, wherein the at least one sensor comprises a plurality of pixels (106) and wherein at least some of the pixels comprise at least two photodiodes (102,103); at least one tunable optical element (104), wherein said at least one tun-able optical element (104) is adapted to vary the focus of the optical system (100); and wherein the optical system (100) is configured for capturing a plurality of images with the at least one sensor (101) at a plurality of focus positions set by the at least one tunable optical element (104).
Patent CA-3167978-A1 (CA)
Title: Composition pharmaceutique comprenant des microspheres a liberation prolongee comportant un analogue de glp -1 ou un sel pharmaceutiquement acceptable de celui-ci
Inventor: NA YONGHA
IPC: A61P3/06
Filed: 2021-02-15
Abstract: La présente invention concerne une composition pharmaceutique permettant de supprimer efficacement des effets secondaires fatals par empêchement de l'éclatement initial rapide d'un médicament au moyen de l'inclusion de microsphères à libération prolongée contenant du sémaglutide, ou un sel, hydrate ou solvate de celui-ci pharmaceutiquement acceptable, et permet de réduire au minimum une réaction douloureuse et inflammatoire chez un patient, laquelle peut se produire pendant l'administration, en ce qu'elle contient une quantité élevée de médicament par rapport à la taille des particules, et peut donc être utile dans la prévention ou le traitement du diabète, de l'hypertension, de l'hyperlipidémie, de l'obésité, de la stéatose hépatique non alcoolique, ou des maladies neurodégénératives telles que la maladie de Parkinson et la maladie d'Alzheimer.
Patent CA-3172857-A1 (CA)
Title: Vascular access device assembly facilitating single-handed probe advancement with a support member
Inventor: BURKHOLZ JONATHAN KARL
IPC: A61B5/154
Filed: 2021-03-11
Abstract: An IV device assembly may include a lumen forming a fluidic channel within the IV device assembly. The lumen may be fluidically coupled to a vascular access device (VAD) coupler via a funnel coupler, and an IV device assembly coupler at a proximal end of the lumen. The IV device assembly may also include one or more of the following: a collapsible sleeve formed coaxially around a first portion of the lumen and mechanically coupled to the funnel coupler, a probe formed along a second portion of the lumen within the collapsible sleeve and into the VAD coupler, a translation handle that translates the probe out of a distal end of the VAD coupler, and a fixed grip formed around the lumen to maintain a position of the IV device assembly relative to the translation handle.
Patent CA-3174141-A1 (CA)
Inventor: EHLERS WILLIAM T
IPC: B43K1/12
Filed: 2021-04-05
Abstract: La présente invention concerne des instruments d'écriture pouvant comprendre des pointes ayant des vides pour visualiser une surface d'écriture lors de leur utilisation. La pointe comprend un corps de pointe fibreuse ayant une partie d'écriture supérieure et une partie d'écriture inférieure configurée pour distribuer de l'encre d'un réservoir d'encre à la partie d'écriture supérieure. La pointe a un ou plusieurs montants allongés qui définissent un vide dans un plan bidimensionnel à travers lequel une surface d'écriture peut être vue lorsqu'elle est utilisée.
Patent CA-3176102-A1 (CA)
Inventor: DURHAM LYNN
IPC: A61P25/00
Filed: 2021-03-19
Abstract: The present invention relates to pharmaceutical compositions for the treatment of a subtype of autism spectrum disorder (ASD) patients. Likewise, the present invention relates to methods of diagnosing a subtype of ASD and methods for identifying patients responding a specific treatment of ASD.
Patent CA-3178951-A1 (CA)
Title: Lymphocyte t, procede de preparation de ce dernier et ses applications
Inventor: SHI YAN
IPC: A61K35/17
Filed: 2020-05-15
Abstract: L'invention concerne un lymphocyte T dépourvu du gène RYR2 et un procédé de préparation. L'invention concerne également les éléments suivants : un antagoniste de RYR2 n; un lymphocyte T surexprimant RYR2; un procédé et des applications pour réguler l'expression de RYR2, réguler l'oscillation fondamentale de Ca ?, réguler l'activité de la m-Calpaïne, et augmenter la force de liaison entre les lymphocytes T et les cellules DC; des applications d'un réactif mettant en ?uvre les fonctions dans la préparation d'un médicament pour traiter une maladie infectieuse, un cancer ou une tumeur; et un procédé pour transformer les lymphocytes Tconv pour qu'ils soient fonctionnellement similaires aux lymphocytes Treg.
Patent CA-3179461-A1 (CA)
Inventor: NASSER SYED MUHAMMAD TAHIR
IPC: A61P31/12
Filed: 2021-05-19
Abstract: La présente invention concerne des compositions pharmaceutiques et des méthodes pour le traitement d'infections respiratoires virales. Plus spécifiquement, la présente invention concerne des antagonistes d'IL-18 et leur utilisation dans le traitement d'une infection respiratoire virale chez un sujet ayant : (a) une déficience de la protéine de liaison à IL-18; et/ou (b) une déficience de cellules tueuses naturelles et/ou une déficience de cellules tueuses naturelles fonctionnelles.
Patent CA-3180559-A1 (CA)
Inventor: KAPPEL BARRY JAY
IPC: A61K38/16
Filed: 2021-06-21
Abstract: L'invention concerne des méthodes d'administration d'un antagoniste peptidique de la protéine bêta de liaison à l'activateur CCAAT (C/????) et des méthodes de traitement de tumeurs solides par administration d'un antagoniste peptidique de C/????.
Patent CA-3182438-A1 (CA)
Inventor: XIAO MENG
IPC: A61K48/00
Filed: 2021-11-08
Abstract: Provided is a method for preparing an adenovirus vector vaccine by means of a perfusion culture process. The method comprises a step of culturing adenovirus host cells, and in particular a step of adjusting the perfusion rate by means of at least two stages according to cell density. The method increases the single cell yield of a virus after infection and the specific activity of a virus harvest liquid while achieving high-density growth of adenovirus host cells.
Patent CA-3188669-A1 (CA)
Title: Resource management concept
Inventor: SCHIERL THOMAS
IPC: H04W72/0457
Filed: 2012-10-22
Abstract: Assignment of resources of a base station for streaming media content from a server to a client, wherein media presentation descriptions are available for different bandwidth requirements for the media content. Resources are assigned based on a media presentation description, in particular for dynamic adaptive streaming over HTTP (DASH).  Also buffer content is taken into account as well as unicast or multicast transmission.
Patent CA-3189780-A1 (CA)
Inventor: HASHEMI AMROABADI SAYEDMASOUD
IPC: G06F21/32
Filed: 2021-07-21
Abstract: An approach for increasing security of biometric templates is described. An improved system is adapted to split a full set of features or representations of a trained model into a first partial template and a second partial template, the second partial template being stored on a secure enclave accessible only through zero-knowledge proof based interfaces. During verification using the template, a new full set of features is received for comparison, and a model is loaded based on the available portions of the model. Comparison utilizing the second partial template requires the computation of zero-knowledge proofs as direct access to the underlying second partial template is prohibited by the secure enclave.
Patent CA-3190386-A1 (CA)
Inventor: RODRIGUEZ GUEVARA BORJA
IPC: B63B1/34
Filed: 2021-03-17
Abstract: A watercraft system including one or more air passageways and/or one or more water passageways is provided. The air passageways may extend from an upper surface of the watercraft, through the body of the watercraft, to an underneath surface of the watercraft. The water passageways may extend from an underneath forward or side portion on the watercraft, through the body of the watercraft, to a rear portion of the watercraft. The air and/or water passageways may be constricting from the inlets to the outlets so that the air and/or water is accelerated through the passageways during use of the craft. In this way, the release of the accelerated air and/or water decreases the craft's drag and provides the craft a forward thrust.
Patent CA-3191492-A1 (CA)
Title: Methods of preparing iron complexes
Inventor: WU CHIEN-CHIN
IPC: A61K47/54
Filed: 2021-09-29
Abstract: A method of preparing an iron hydroxide product is provided. The method includes the steps of: adding a first base solution to a solution of a ferric salt to obtain Mixture A having a pH value of 2.7-2.8, adding a second base solution to Mixture A to prepare a crude iron hydroxide suspension having a pH value of 2.8-3.8, and adding a third base solution to adjust the pH of the crude iron hydroxide suspension to 5-9, followed by purification and concentration, thereby obtaining a purified polynuclear iron hydroxide suspension containing polynuclear iron hydroxide. Also provided are nano iron complexes, e.g., iron hydroxide carbohydrate complex and their preparation methods.